Novavax, Inc.
NVAX
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.2B
Close$
$24.78
223.6% upside
Current Fair Value
223.6% upsideUndervalued by 223.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.20 Billion |
|---|---|
| Enterprise Value | $1.36 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.72 |
| Beta | 2.43 |
| Outstanding Shares | 163,276,000 |
Return
| Return on Equity | 60.68% |
|---|---|
| Return on Assets | -8.42% |
| Return on Invested Capital | -3.33% |
Valuation & Multiples
| P/E Ratio | -13.56 |
|---|---|
| PEG | 13.31 |
| Price to Sales | 2.55 |
| Price to Book Ratio | -7.66 |
| Enterprise Value to Revenue | 2.28 |
| Enterprise Value to EBIT | -58.33 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | -2.65 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
$78.32 M
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
$51.10 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 131.92% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.49%▼ 67.34% |
|---|---|
| Total Invested | $84.51M▼ 91.20% |
| Investors Holding | 64▼ 220.00% |
ESG Score
No data
About Novavax, Inc.
CEO: Stanley Erck